Health Care Roundup: Market Talk

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.

1037 ET – Apotex could find itself in a bind after President Trump’s threat to impose tariffs up to 200% on generic drugs made outside the U.S. Apotex, which recently went public, is down about 10% at C$35.72 as Trump says the levies would begin at 100% in August 2028 and rise a year later, giving drugmakers time to shift manufacturing. The plan targets generic medicines largely produced in India and China. Most of Apotex’s production is in Canada, with additional facilities in Mexico and India, and only two U.S. sites focused on warehousing, distribution and its U.S. affiliate headquarters. ([email protected])

Copyright ©2026 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

investment News
newsplus,Pharmaceuticals,Healthcare/Life Sciences,Generic/Biosimilar Drugs,Manufacturing,Dragonfly – North America,Dragonfly – World,North America,United States,Trade/External Payments,Economic News,Political/General News,International Relations,Health/Medicine,Politics/International Relations,Trade Barriers/Restrictions,SYND,WSJ-PRO-WSJ.com,GCAPI,LINK:EN|drn:realtime.linkedarticle.DNCO20260722006494,trade,external payments,political,general news,health,medicine,politics,trade barriers,restrictions,healthcare,life sciences,generic,biosimilar drugs

Author

  • Peter Lynch

    Lynch co-authored several bestselling investment classics, including One Up on Wall Street, Beating the Street, and Learn to Earn. Known for his accessible and common-sense approach to the stock market, he coined the famous investment mantra, "Invest in what you know." This philosophy empowers everyday individual investors to find market-beating opportunities by observing consumer trends and products in their own daily lives before Wall Street notices them.Beyond his writing and investing career, Lynch is a prominent philanthropist. He works actively through the Lynch Foundation to support education, medical research, and cultural organizations. He continues to serve as a vice chairman of Fidelity Management & Research Company, mentoring new generations of financial analysts.

Peter Lynch

https://investmentdepartment.com

Lynch co-authored several bestselling investment classics, including One Up on Wall Street, Beating the Street, and Learn to Earn. Known for his accessible and common-sense approach to the stock market, he coined the famous investment mantra, "Invest in what you know." This philosophy empowers everyday individual investors to find market-beating opportunities by observing consumer trends and products in their own daily lives before Wall Street notices them.Beyond his writing and investing career, Lynch is a prominent philanthropist. He works actively through the Lynch Foundation to support education, medical research, and cultural organizations. He continues to serve as a vice chairman of Fidelity Management & Research Company, mentoring new generations of financial analysts.